Publication date: Nov 05, 2019
The use of ketamine in palliative care is becoming more common for challenging symptom management, namely cancer related pain and psychiatric conditions. However, there is much that remains unstudied and uncertain about ketamine’s clinical utility. In this case we examine a young cancer patient who was struggling with challenging neuropathic pain and significant existential anguish in the setting of metastatic pancreatic cancer and delirium. Despite concerns regarding baseline delirium we successfully used ketamine to better manage neuropathic pain, decrease overall opioid need, without exacerbating the preexisting delirium. Our case highlights the benefits of ketamine for neuropathic pain control in the face of delirium.
Moazam, C., Hirst, J., Mesarwi, P., and Atayee, R.S. Ketamine: When Delirium and Desperation Call for a Hero. 04204. 2019 J Pain Palliat Care Pharmacother.
- The use of ketamine in the management of refractory cancer pain in a palliative care unit.
- Hospital Opioid Requirements Following Continuation Versus Discontinuation of Buprenorphine for Addiction – A Retrospective Cohort Study.
- Pearls for opioid use in seriously ill patients.
- Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board.
- Innovative Non-Opioids for Chronic Pain: Ketamine and Cannabidiol
- Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose